giant Denagard Powder politely

fundamental Denagard Powder color
 
Photo :Denagard Powder

most up-to-date Denagard Powder Generic Name: tiamulin Dosage Form: FOR ANIMAL USE ONLY Denagard-Medicated Premix Denagard 10 (tiamulin) Medicated Premix Type A Medicated Article For manufacture of medicated swine feed only Active Ingredient: Tiamulin (as hydrogen fumarate): 10 g/lb Ingredients : roughage product, mineral oil See reverse side for use directions, cautions and warnings. NADA 139-472, Approved by FDA Net Weight: 35 lb (15.9 kg) Denagard 10 (tiamulin) Medicated Premix Type A Medicated Article For use in animals only. Store in a dry place. Indications Directions Amount of Denagard 10 Per Ton Tiamulin in Complete Feed Per Ton Withdrawal Period (days) For treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin Feed continuously as the sole ration for 14 days 20 lb 200 g 7 For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis Feed continuously as the sole ration for not less than 10 days 3.5 lb 35 g 2 For control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin Feed continuously as the sole ration 3.5 lb 35 g 2 Warning: Observe withdrawal time shown in table above. Keep out of reach of children. Avoid contact with skin. Direct contact with skin or mucous membranes may cause irritation. Caution: Do not feed undiluted. Do not use in feeds for animals other than swine. The effects of tiamulin on swine reproductive performance, pregnancy and lactation have not been determined. Contraindications: Swine being treated with Denagard (tiamulin) should not have access to feeds containing polyether ionophores (e.g., lasalocid, monensin. narasin, salinomycin and semduramicin) as adverse reactions may occur. If signs of toxicity occur, discontinue use. Restricted Drug (California): Use only as directed. For more information or to report adverse effects, call 1-800-637-0281. Denagard is a registered trademark of Novartis AG. Product #700 NAH/DEN10-MP/BL/3 Marketed by: Novartis Animal Health US, Inc. Greensboro, NC 27408 U.S.A. Principal Display Panel Denagard 10 (tiamulin) Medicated Premix Type A Medicated Article Net Weight: 35 lb (15.9 kg) NOVARTIS ANIMAL HEALTH DENAGARD 10 tiamulin powder Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:58198-0700 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TIAMULIN FUMARATE (TIAMULIN) TIAMULIN FUMARATE 22 g in 1 kg Packaging # Item Code Package Description 1 NDC:58198-0700-1 15.9 kg in 1 BAG Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NADA NADA139472 07/17/1987 Labeler - Novartis Animal Health US, Inc. (966985624) Revised: 12/2009 Novartis Animal Health US, Inc. Print this page FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More exercises


many synthetic Denagard Powder a variety of


EmoticonEmoticon